Vivek Kashyap to Mycobacterium tuberculosis
This is a "connection" page, showing publications Vivek Kashyap has written about Mycobacterium tuberculosis.
Connection Strength
0.398
-
Chouhan M, Kumar M, Dwivedi VD, Kashyap VK, Singh HN, Kumar S. Harnessing Natural Product Compounds to Target Dormancy Survival Regulator (DosR) in Latent Tuberculosis Infection (LTBI): An In Silico Strategy Against Dormancy. Adv Respir Med. 2025 Jun 16; 93(3).
Score: 0.208
-
Singh S, Roy KK, Khan SR, Kashyap VK, Sharma A, Jaiswal S, Sharma SK, Krishnan MY, Chaturvedi V, Lal J, Sinha S, Dasgupta A, Gupta AD, Srivastava R, Saxena AK. Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis. Bioorg Med Chem. 2015 Feb 15; 23(4):742-52.
Score: 0.101
-
Saxena AK, Roy KK, Singh S, Vishnoi SP, Kumar A, Kashyap VK, Kremer L, Srivastava R, Srivastava BS. Identification and characterisation of small-molecule inhibitors of Rv3097c-encoded lipase (LipY) of Mycobacterium tuberculosis that selectively inhibit growth of bacilli in hypoxia. Int J Antimicrob Agents. 2013 Jul; 42(1):27-35.
Score: 0.090